LOS ANGELES–(BUSINESS WIRE)—- $NAGE #Biotech–Niagen Bioscience, Inc. (NASDAQ: NAGE), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the science of healthy aging, today announced a Start-Up Agreement with Mass General Brigham (MGB) to begin detailed planning for what is envisioned to be the largest and most…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
